Clinical trial Recruiting at 1 site Observational Ages 5 to 99

Examining brain changes in children with Williams syndrome

Official title: Defining the Brain Phenotype of Children With 7q11.23 Copy Number Variation, Including Williams Syndrome and 7q11.23 Duplication Syndrome

Run by National Institutes of Health Clinical Center (CC) · NCT01132885 · Data updated 2026-11-12

This study looks at how the brains of children with Williams syndrome and similar genetic conditions develop compared to healthy kids, using MRI scans to see the differences.

Quick facts

Study typeObservational
Ages5 Years to 99 Years
SexAll
Enrollment415 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedJanuary 23, 2011
Registry record updatedOctober 29, 2026
Trial IDNCT01132885 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include children and adolescents aged 5 to 17 with a diagnosis of Williams syndrome, 7q11.23 duplication syndrome, or other related genetic variations, as well as healthy children in the same age range.

Probably not a fit

Patients with chronic or acute medical conditions that could interfere with MRI data interpretation or task performance may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate how the brains of children with Williams syndrome and other genetic variations on chromosome 7q11.23 develop compared to healthy children. Researchers will utilize magnetic resonance imaging (MRI) to assess brain structure and function in participants aged 5 to 17 years. The study will include both healthy children and those diagnosed with Williams syndrome or related conditions, focusing on understanding the neurodevelopmental changes associated with these genetic variations. Participants will undergo physical examinations and cognitive tests to gather comprehensive data on their brain development.

Why it matters

Potential benefit: If successful, this study could enhance our understanding of the neurodevelopmental impacts of Williams syndrome, potentially leading to better-targeted interventions and support for affected individuals.

How similar studies have gone: Previous neuroimaging studies in adults with Williams syndrome have successfully identified specific brain phenotypes, suggesting that this approach may yield valuable insights in children as well.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

For all participants, the following inclusion criteria will apply:

1. Greater than 5 years old.
2. Able to provide assent if below the age of 18, or consent if 18 years of age or older. Parents will provide consent for participants below the age of 18. For patients who do not have the capacity to provide informed consent, consent may be obtained from a guardian or the holder of the DPA.

Additionally, 7q11.23 CNV participants must have a typical, 7q11.23 CNV or other genetic abnormality in the Williams syndrome critical region of chromosome 7q11.23, and control participants must have normal intelligence.

EXCLUSION CRITERIA:

For all participants who will participate in MRI scanning, the following exclusion criteria will apply:

1. Any chronic or acute medical condition severe enough to interfere with task performance or interpretation of MRI data.
2. Any medication that might interfere with task performance or interpretation of MRI data.
3. Any medical condition that increases risk for MRI (e.g. pacemaker, metallic foreign body in eye or other body part, dental braces).
4. Pregnancy (a urine pregnancy test will be performed prior to all MRI procedures for all females of child-bearing potential.
5. NIMH employees and staff and their immediate family members will be excluded from the study per NIMH policy.

For parents who will undergo blood draws only, they will not be able to participate if they have a condition

that would make collecting blood unsafe.

Where it's running

  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Karen F Berman, M.D. — National Institute of Mental Health (NIMH)
  • Study coordinator: Tiffany A Nash
  • Email: tiffany.nash@nih.gov
  • Phone: (240) 205-0333

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.